 Connection
Mary Demoruelle to Antirheumatic Agents
This is a "connection" page, showing publications Mary Demoruelle has written about Antirheumatic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.254 |
|
|
|
-
Deane KD, Striebich CC, Feser ML, O'Dell JR, James JA, Sparks JA, Davis JM, Graf J, McMahon MA, Solow EB, Forbess LJ, Tiliakos A, Schiopu E, Danila MI, Horowitz DL, Kay J, Strickland CD, Guthridge JM, Arriens C, Grossman JM, Kristen Demoruelle M, Bemis EA, Frazer-Abel A, Fleischer CL, Fox DA, Mikuls TR, Greenleaf M, York K, Walker S, Keyes-Elstein L, Byron M, Fedler J, Goldmuntz EA, Holers VM. A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis. Arthritis Rheumatol. 2026 Apr; 78(4):809-820.
Score: 0.774
-
Demoruelle MK, Deane KD. Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis. Curr Rheumatol Rep. 2012 Oct; 14(5):472-80.
Score: 0.305
-
Marcy D, Zell J, Demoruelle MK. Rheumatoid Arthritis and Pregnancy: Managing Disease Activity and Fertility Concerns. Semin Reprod Med. 2024 09; 42(3):169-177.
Score: 0.176
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|